Archive for May, 2011

DUSA Pharmaceuticals (DUSA) stock spikes on earnings report

Thursday, May 5th, 2011

DUSA Pharmaceuticals Inc. (Nasdaq: DUSA) shares rallied 22.5% to $5.55, after the developer of dermatology products reported first-quarter results. Volume for the stock topped 2.2 million shares shortly before Thursday’s close, compared to a daily average of 350,000.

The company, based out of Wilmington, Massachusetts, reported total product revenues were $11.1 million for the quarter, representing a $2.4 million or 27% year-over-year improvement, and experienced a net loss on a GAAP basis of $600,000 or $0.02 per common share for the first quarter of 2011, compared to a net loss of $400,000 or $0.02 per common share in the first quarter of 2010.

According to DUSA Chief Executive Officer Robert Doman, “We are off to a great start in 2011. Continued growth of our core domestic PDT revenues, as well as record gross margins, drove significant year-over-year improvement in our non-GAAP profitability and cash flow.” Doman concluded, “The results of the quarter are even more impressive given the fact that they followed our record performance of the fourth quarter of 2010.”

DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan® PDT technology platform, and other dermatology products. Levulan® Kerastick® for topical solution plus DUSA’s BLU-U® Blue Light Photodynamic Therapy Illuminator is currently approved for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp.

Kendle International (KNDL) stocks soar on news of acquisition

Thursday, May 5th, 2011

Kendle International Inc. (Nasdaq: KNDL) shares rose 57.8% Thursday to $14.99, a day after INC Research LLC said it would acquire the clinical research group for $232 million, or $15.25 a share. Volume for the stock was 3.2 million in the just the first hour of trading, compared to an all-day average around 158,000.

The purchase price represents a 60.5% premium over Kendle’s closing share price on May 4, and a 51.3% premium over the 30-trading day average of Kendle’s closing price. Kendle’s Board of Directors of unanimously approved the transaction, which is expected to close in the third quarter.

Kendle CEO Stephen Cutler commented, “Joining forces with INC Research is the right decision for our customers and shareholders. Combining our highly complementary assets will provide the scale and scope for the combined company to deliver outstanding global teams, therapeutic expertise and operational excellence for clinical trials of all sizes.”

Concurred INC CEO James Ogle, “The combination of INC Research and Kendle will enable us to deliver broader capabilities and reach a critical mass for the emerging drug development outsourcing and alliance partnership models. Together, we bring complementary strengths and expand the breadth and depth of services and expertise that are most valuable to our customers.”

INC based in Raleigh, North Carolina, is a therapeutically focused global contract research organization (CRO) privately held by Avista Capital Partners and Ontario Teachers’ Pension Plan.

Kendle International, headquartered in Cincinnati, is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world’s biopharmaceutical industry.

FEI Co. (FEIC) shares get boost on Q2 earnings

Wednesday, May 4th, 2011

FEI Co. (Nasdaq: FEIC) shares gained 8.9% to $34.59 Wednesday, a day after the high-precision microscope maker projected second-quarter results that topped Wall Street’s forecasts. Volume for the stock was 1.1 million shares shortly before Wednesday’s closing bell, compared to a daily average of 352,000.

The company, based in Hillsboro, Oregon, reported the highest quarterly revenue and earnings in the company’s history. Revenue of $197 million was up 32% compared to $149.1 million in the first quarter of 2010 and up 6% from $186.1 million in the fourth quarter of 2010.

Net income was $22.3 million or $0.54 per diluted share, compared with $4.1 million or $0.11 per diluted share in the first quarter of 2010 and $21.3 million or $0.52 per diluted share in the fourth quarter of 2010.

FEI’s Chief Executive Officer, Don Kania, commented, “Gross margins moderated from the fourth quarter as expected, as operating margins increased. Bookings remained strong with 31% year-over-year growth in both Life Sciences and Research and Industry, and 14% growth in Electronics. For the second quarter, we expect revenue to be strong with improved gross margins, and we continue to expect growth for 2011.”

FEI is a leading diversified scientific instruments company. It is a premier provider of electron and ion-beam microscopes and tools for nanoscale applications globally and across many industries: industrial and academic materials research, life sciences, semiconductors, data storage, natural resources and more.

Varian Semiconductor Equipment Associates (VSEA) stocks skyrocket on news of impending takeover

Wednesday, May 4th, 2011

Varian Semiconductor Equipment Associates Inc.’s (Nasdaq: VSEA) shares surged 51.1% to $61.29 Wednesday, after Applied Materials Inc. (Nasdaq: AMAT) said it would acquire the ion-implantation equipment supplier for $4.9 billion. Volume for Varian was 18.3 million shares before noon ET, overwhelming a full-day average of 1.2 million.

Santa Clara, California-based Applied Materials says it will pay $63 a share, or 55% more than yesterday’s closing price. It also said the merger was approved by the boards of directors of both companies. Varian is based in Gloucester, Massachusetts.

Applied Materials Chief Executive Officer Mike Splinter said “Varian is a great fit for our strategy to profitably grow share in our core semiconductor business with best-in-class technology and talent.

“The pace of product innovation is accelerating, requiring devices that are more mobile, more connected and more personalized.”

Varian management was not available for comment.

International Coal Group Inc. (ICO) takeover target sees price soar

Monday, May 2nd, 2011

International Coal Group Inc. (NYSE: ICO) shares climbed 30.9% Monday to $14.44, after Arch Coal Inc. (NYSE: ACI) said it would buy the coal miner for $3.4 billion. Volume for International Coal stock was a towering 153.5 million shares, overwhelming a daily average of around 7.8 million.

The combined company will be the second largest U.S. metallurgical coal supplier and a top-five overall global coal producer and marketer. Arch will have a balanced metallurgical (“met”) and thermal coal portfolio with unparalleled operational diversification in every major U.S. supply basin and the No. 1 or No. 2 position in each of its three core operating regions.

“The acquisition of ICG is a significant strategic step that strengthens Arch’s position as a world-class, global coal franchise positioned for growth,” said Arch CEO Steven F. Leer.

“This transaction will greatly expand our participation in global met markets; provide a powerful platform for future organic met coal production growth; enhance and further diversify our met and thermal coal product slate; extend our operating portfolio into every major U.S. coal-producing basin; and solidify our position as one of the industry’s lowest cost producers.”

Ben Hatfield, president and CEO of International Coal Group, said, “ICG has assembled a high-quality portfolio of low-cost mining operations and reserves, and one of the industry’s most talented and productive workforces. By teaming up with Arch, we expect to realize tremendous value for the shareholders of both companies while ensuring that our operations achieve their full potential.”

ICG is a leading producer of coal in Northern and Central Appalachia and the Illinois Basin. The company has 13 active mining complexes, of which 12 are located in Northern and Central Appalachia and one in Central Illinois. ICG’s mining operations and reserves are strategically located to serve utility, metallurgical and industrial customers domestically and internationally.

Arch Coal is one of the world’s largest coal producers, with more than 160 million tons of coal sold in 2010. Arch’s national network of mines supplies cleaner-burning, low-sulfur coal to customers on four continents, including U.S. and international power producers and steel manufacturers. In 2010, Arch achieved record revenues of $3.2 billion.